SCHEMBL18436267

SCHEMBL18436267

CC(C)(O)c1ccc(NCCNc2cnc3c(-c4ccc(C#N)cc4)cccc3c2C(F)(F)F)nc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.34
CCR6 P51684 2/20 0.33
USP1 O94782 1/20 0.33
WDR48 Q8TAF3 1/20 0.33
DYRK3 O43781 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
DYRK1A Q13627 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32
STK17A Q9UEE5 1/20 0.32
PRKAB2 O43741 1/20 0.32
PRKAG1 P54619 1/20 0.32
PRKAA2 P54646 1/20 0.32
PRKAA1 Q13131 1/20 0.32
PRKAG3 Q9UGI9 1/20 0.32
PRKAG2 Q9UGJ0 1/20 0.32
PRKAB1 Q9Y478 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32
CYP11B2 P19099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21336865 0.90 ENPP1 (0.39) DPP4PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL21336795 0.86 NTRK1 (0.33) DPP4GSK3BSLC22A12CNR2KDM4A
SCHEMBL18436916 0.85 DPP4 (0.34) DPP4CCR6
SCHEMBL18436479 0.84 GABRA5 (0.35) VNN1
SCHEMBL18436867 0.78 ENPP1 (0.34) USP1WDR48KDM4AKDM5B
SCHEMBL21336578 0.75 TTK (0.32) SLC22A12KDM4AKDM5B
SCHEMBL17128125 0.75 MAOB (0.41)
SCHEMBL18436403 0.73 EGLN1 (0.34) SLC22A12
SCHEMBL18436478 0.71 EGLN1 (0.36) VNN1KDM4AKDM5B
SCHEMBL18436758 0.71 KDM1A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124482-B1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD (CN) 2019-09-11 EP disclosed
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 EP disclosed